[Webinar] Development and Characterization of Biopharmaceuticals Using Lipid Nanoparticles

Production of LNPs of perfect size, evaluation of size and quality characteristics, buffer exchange and sample concentration, and upgrading of stability analysis methods.

Lipid nanoparticles (LNPs) are currently one of the most notable delivery systems used in mRNA vaccines, gene therapy, cancer treatment, and more. However, their development requires a complex process involving formulation screening, control of size and quality, removal of organic solvents, and characterization, which demands significant effort and time. In this webinar, we will introduce methods to enhance the production of perfectly sized LNPs, evaluate their size and quality characteristics, perform buffer exchange and sample concentration, and analyze stability at each step of the development process workflow. ■ Date and Time: March 27 (Monday) 14:00~ ■ Speaker: Yukinori Ooshiro, Field Application Scientist at Unchained Labs ■ Register here: https://unchainedlabs.zoom.us/webinar/register/5816780852848/WN_ycxoqBXnScOgpzBx1dQ16g

Other protein analysis